Medical Care
Global Injectable Targeted Therapy Market Research Report 2024
- Apr 15, 24
- ID: 169487
- Pages: 80
- Figures: 170
- Views: 21
It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Will affect the normal tissue cells around the tumor.
The global Injectable Targeted Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Injectable Targeted Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Injectable Targeted Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Injectable Targeted Therapy in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Injectable Targeted Therapy include Novartis, Sanofi, GSK, Bayer, Amgen, Merck, AbbiVie, AstraZeneca and Teva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Injectable Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Targeted Therapy.
Report Scope
The Injectable Targeted Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sanofi
GSK
Bayer
Amgen
Merck
AbbiVie
AstraZeneca
Teva
Roche
Pfizer
Segment by Type
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Others
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Targeted Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Injectable Targeted Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Injectable Targeted Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Injectable Targeted Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Injectable Targeted Therapy in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Injectable Targeted Therapy include Novartis, Sanofi, GSK, Bayer, Amgen, Merck, AbbiVie, AstraZeneca and Teva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Injectable Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Targeted Therapy.
Report Scope
The Injectable Targeted Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sanofi
GSK
Bayer
Amgen
Merck
AbbiVie
AstraZeneca
Teva
Roche
Pfizer
Segment by Type
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Others
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Targeted Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Small-Molecules
1.2.4 Immunotoxins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable Targeted Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Targeted Therapy Market Perspective (2019-2030)
2.2 Injectable Targeted Therapy Growth Trends by Region
2.2.1 Global Injectable Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Injectable Targeted Therapy Historic Market Size by Region (2019-2024)
2.2.3 Injectable Targeted Therapy Forecasted Market Size by Region (2025-2030)
2.3 Injectable Targeted Therapy Market Dynamics
2.3.1 Injectable Targeted Therapy Industry Trends
2.3.2 Injectable Targeted Therapy Market Drivers
2.3.3 Injectable Targeted Therapy Market Challenges
2.3.4 Injectable Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Targeted Therapy Players by Revenue
3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2019-2024)
3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Targeted Therapy Revenue
3.4 Global Injectable Targeted Therapy Market Concentration Ratio
3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2023
3.5 Injectable Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Injectable Targeted Therapy Product Solution and Service
3.7 Date of Enter into Injectable Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Targeted Therapy Breakdown Data by Type
4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2019-2024)
4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2025-2030)
5 Injectable Targeted Therapy Breakdown Data by Application
5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2019-2024)
5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Injectable Targeted Therapy Market Size (2019-2030)
6.2 North America Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Injectable Targeted Therapy Market Size by Country (2019-2024)
6.4 North America Injectable Targeted Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable Targeted Therapy Market Size (2019-2030)
7.2 Europe Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Injectable Targeted Therapy Market Size by Country (2019-2024)
7.4 Europe Injectable Targeted Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Targeted Therapy Market Size (2019-2030)
8.2 Asia-Pacific Injectable Targeted Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable Targeted Therapy Market Size (2019-2030)
9.2 Latin America Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Injectable Targeted Therapy Market Size by Country (2019-2024)
9.4 Latin America Injectable Targeted Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Targeted Therapy Market Size (2019-2030)
10.2 Middle East & Africa Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Targeted Therapy Introduction
11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Injectable Targeted Therapy Introduction
11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Injectable Targeted Therapy Introduction
11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2019-2024)
11.3.5 GSK Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Injectable Targeted Therapy Introduction
11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Amgen
11.5.1 Amgen Company Detail
11.5.2 Amgen Business Overview
11.5.3 Amgen Injectable Targeted Therapy Introduction
11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2019-2024)
11.5.5 Amgen Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Injectable Targeted Therapy Introduction
11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2019-2024)
11.6.5 Merck Recent Development
11.7 AbbiVie
11.7.1 AbbiVie Company Detail
11.7.2 AbbiVie Business Overview
11.7.3 AbbiVie Injectable Targeted Therapy Introduction
11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2019-2024)
11.7.5 AbbiVie Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Injectable Targeted Therapy Introduction
11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Injectable Targeted Therapy Introduction
11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2019-2024)
11.9.5 Teva Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Injectable Targeted Therapy Introduction
11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2019-2024)
11.10.5 Roche Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Injectable Targeted Therapy Introduction
11.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2019-2024)
11.11.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Small-Molecules
1.2.4 Immunotoxins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable Targeted Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Targeted Therapy Market Perspective (2019-2030)
2.2 Injectable Targeted Therapy Growth Trends by Region
2.2.1 Global Injectable Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Injectable Targeted Therapy Historic Market Size by Region (2019-2024)
2.2.3 Injectable Targeted Therapy Forecasted Market Size by Region (2025-2030)
2.3 Injectable Targeted Therapy Market Dynamics
2.3.1 Injectable Targeted Therapy Industry Trends
2.3.2 Injectable Targeted Therapy Market Drivers
2.3.3 Injectable Targeted Therapy Market Challenges
2.3.4 Injectable Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Targeted Therapy Players by Revenue
3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2019-2024)
3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Targeted Therapy Revenue
3.4 Global Injectable Targeted Therapy Market Concentration Ratio
3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2023
3.5 Injectable Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Injectable Targeted Therapy Product Solution and Service
3.7 Date of Enter into Injectable Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Targeted Therapy Breakdown Data by Type
4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2019-2024)
4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2025-2030)
5 Injectable Targeted Therapy Breakdown Data by Application
5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2019-2024)
5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Injectable Targeted Therapy Market Size (2019-2030)
6.2 North America Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Injectable Targeted Therapy Market Size by Country (2019-2024)
6.4 North America Injectable Targeted Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable Targeted Therapy Market Size (2019-2030)
7.2 Europe Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Injectable Targeted Therapy Market Size by Country (2019-2024)
7.4 Europe Injectable Targeted Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Targeted Therapy Market Size (2019-2030)
8.2 Asia-Pacific Injectable Targeted Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable Targeted Therapy Market Size (2019-2030)
9.2 Latin America Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Injectable Targeted Therapy Market Size by Country (2019-2024)
9.4 Latin America Injectable Targeted Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Targeted Therapy Market Size (2019-2030)
10.2 Middle East & Africa Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Targeted Therapy Introduction
11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Injectable Targeted Therapy Introduction
11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Injectable Targeted Therapy Introduction
11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2019-2024)
11.3.5 GSK Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Injectable Targeted Therapy Introduction
11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Amgen
11.5.1 Amgen Company Detail
11.5.2 Amgen Business Overview
11.5.3 Amgen Injectable Targeted Therapy Introduction
11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2019-2024)
11.5.5 Amgen Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Injectable Targeted Therapy Introduction
11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2019-2024)
11.6.5 Merck Recent Development
11.7 AbbiVie
11.7.1 AbbiVie Company Detail
11.7.2 AbbiVie Business Overview
11.7.3 AbbiVie Injectable Targeted Therapy Introduction
11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2019-2024)
11.7.5 AbbiVie Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Injectable Targeted Therapy Introduction
11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Injectable Targeted Therapy Introduction
11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2019-2024)
11.9.5 Teva Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Injectable Targeted Therapy Introduction
11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2019-2024)
11.10.5 Roche Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Injectable Targeted Therapy Introduction
11.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2019-2024)
11.11.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Injectable Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small-Molecules
Table 4. Key Players of Immunotoxins
Table 5. Key Players of Others
Table 6. Global Injectable Targeted Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Injectable Targeted Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Injectable Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Injectable Targeted Therapy Market Share by Region (2019-2024)
Table 10. Global Injectable Targeted Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Injectable Targeted Therapy Market Share by Region (2025-2030)
Table 12. Injectable Targeted Therapy Market Trends
Table 13. Injectable Targeted Therapy Market Drivers
Table 14. Injectable Targeted Therapy Market Challenges
Table 15. Injectable Targeted Therapy Market Restraints
Table 16. Global Injectable Targeted Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Injectable Targeted Therapy Market Share by Players (2019-2024)
Table 18. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2023)
Table 19. Ranking of Global Top Injectable Targeted Therapy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Injectable Targeted Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Injectable Targeted Therapy Product Solution and Service
Table 23. Date of Enter into Injectable Targeted Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Injectable Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Injectable Targeted Therapy Revenue Market Share by Type (2019-2024)
Table 27. Global Injectable Targeted Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Injectable Targeted Therapy Revenue Market Share by Type (2025-2030)
Table 29. Global Injectable Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Injectable Targeted Therapy Revenue Market Share by Application (2019-2024)
Table 31. Global Injectable Targeted Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Injectable Targeted Therapy Revenue Market Share by Application (2025-2030)
Table 33. North America Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Injectable Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 48. Novartis Company Detail
Table 49. Novartis Business Overview
Table 50. Novartis Injectable Targeted Therapy Product
Table 51. Novartis Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Sanofi Company Detail
Table 54. Sanofi Business Overview
Table 55. Sanofi Injectable Targeted Therapy Product
Table 56. Sanofi Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 57. Sanofi Recent Development
Table 58. GSK Company Detail
Table 59. GSK Business Overview
Table 60. GSK Injectable Targeted Therapy Product
Table 61. GSK Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 62. GSK Recent Development
Table 63. Bayer Company Detail
Table 64. Bayer Business Overview
Table 65. Bayer Injectable Targeted Therapy Product
Table 66. Bayer Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Amgen Company Detail
Table 69. Amgen Business Overview
Table 70. Amgen Injectable Targeted Therapy Product
Table 71. Amgen Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Merck Company Detail
Table 74. Merck Business Overview
Table 75. Merck Injectable Targeted Therapy Product
Table 76. Merck Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 77. Merck Recent Development
Table 78. AbbiVie Company Detail
Table 79. AbbiVie Business Overview
Table 80. AbbiVie Injectable Targeted Therapy Product
Table 81. AbbiVie Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 82. AbbiVie Recent Development
Table 83. AstraZeneca Company Detail
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Injectable Targeted Therapy Product
Table 86. AstraZeneca Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 87. AstraZeneca Recent Development
Table 88. Teva Company Detail
Table 89. Teva Business Overview
Table 90. Teva Injectable Targeted Therapy Product
Table 91. Teva Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 92. Teva Recent Development
Table 93. Roche Company Detail
Table 94. Roche Business Overview
Table 95. Roche Injectable Targeted Therapy Product
Table 96. Roche Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 97. Roche Recent Development
Table 98. Pfizer Company Detail
Table 99. Pfizer Business Overview
Table 100. Pfizer Injectable Targeted Therapy Product
Table 101. Pfizer Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 102. Pfizer Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Targeted Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Injectable Targeted Therapy Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Small-Molecules Features
Figure 5. Immunotoxins Features
Figure 6. Others Features
Figure 7. Global Injectable Targeted Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Injectable Targeted Therapy Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Homecare Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Injectable Targeted Therapy Report Years Considered
Figure 14. Global Injectable Targeted Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Injectable Targeted Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Injectable Targeted Therapy Market Share by Region: 2023 VS 2030
Figure 17. Global Injectable Targeted Therapy Market Share by Players in 2023
Figure 18. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Injectable Targeted Therapy Revenue in 2023
Figure 20. North America Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Injectable Targeted Therapy Market Share by Country (2019-2030)
Figure 22. United States Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Injectable Targeted Therapy Market Share by Country (2019-2030)
Figure 26. Germany Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Injectable Targeted Therapy Market Share by Region (2019-2030)
Figure 34. China Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Injectable Targeted Therapy Market Share by Country (2019-2030)
Figure 42. Mexico Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Injectable Targeted Therapy Market Share by Country (2019-2030)
Figure 46. Turkey Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 50. GSK Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 51. Bayer Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 52. Amgen Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 53. Merck Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 54. AbbiVie Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 55. AstraZeneca Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 56. Teva Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 57. Roche Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Injectable Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small-Molecules
Table 4. Key Players of Immunotoxins
Table 5. Key Players of Others
Table 6. Global Injectable Targeted Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Injectable Targeted Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Injectable Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Injectable Targeted Therapy Market Share by Region (2019-2024)
Table 10. Global Injectable Targeted Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Injectable Targeted Therapy Market Share by Region (2025-2030)
Table 12. Injectable Targeted Therapy Market Trends
Table 13. Injectable Targeted Therapy Market Drivers
Table 14. Injectable Targeted Therapy Market Challenges
Table 15. Injectable Targeted Therapy Market Restraints
Table 16. Global Injectable Targeted Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Injectable Targeted Therapy Market Share by Players (2019-2024)
Table 18. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2023)
Table 19. Ranking of Global Top Injectable Targeted Therapy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Injectable Targeted Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Injectable Targeted Therapy Product Solution and Service
Table 23. Date of Enter into Injectable Targeted Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Injectable Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Injectable Targeted Therapy Revenue Market Share by Type (2019-2024)
Table 27. Global Injectable Targeted Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Injectable Targeted Therapy Revenue Market Share by Type (2025-2030)
Table 29. Global Injectable Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Injectable Targeted Therapy Revenue Market Share by Application (2019-2024)
Table 31. Global Injectable Targeted Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Injectable Targeted Therapy Revenue Market Share by Application (2025-2030)
Table 33. North America Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Injectable Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 48. Novartis Company Detail
Table 49. Novartis Business Overview
Table 50. Novartis Injectable Targeted Therapy Product
Table 51. Novartis Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Sanofi Company Detail
Table 54. Sanofi Business Overview
Table 55. Sanofi Injectable Targeted Therapy Product
Table 56. Sanofi Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 57. Sanofi Recent Development
Table 58. GSK Company Detail
Table 59. GSK Business Overview
Table 60. GSK Injectable Targeted Therapy Product
Table 61. GSK Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 62. GSK Recent Development
Table 63. Bayer Company Detail
Table 64. Bayer Business Overview
Table 65. Bayer Injectable Targeted Therapy Product
Table 66. Bayer Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Amgen Company Detail
Table 69. Amgen Business Overview
Table 70. Amgen Injectable Targeted Therapy Product
Table 71. Amgen Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Merck Company Detail
Table 74. Merck Business Overview
Table 75. Merck Injectable Targeted Therapy Product
Table 76. Merck Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 77. Merck Recent Development
Table 78. AbbiVie Company Detail
Table 79. AbbiVie Business Overview
Table 80. AbbiVie Injectable Targeted Therapy Product
Table 81. AbbiVie Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 82. AbbiVie Recent Development
Table 83. AstraZeneca Company Detail
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Injectable Targeted Therapy Product
Table 86. AstraZeneca Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 87. AstraZeneca Recent Development
Table 88. Teva Company Detail
Table 89. Teva Business Overview
Table 90. Teva Injectable Targeted Therapy Product
Table 91. Teva Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 92. Teva Recent Development
Table 93. Roche Company Detail
Table 94. Roche Business Overview
Table 95. Roche Injectable Targeted Therapy Product
Table 96. Roche Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 97. Roche Recent Development
Table 98. Pfizer Company Detail
Table 99. Pfizer Business Overview
Table 100. Pfizer Injectable Targeted Therapy Product
Table 101. Pfizer Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)
Table 102. Pfizer Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Targeted Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Injectable Targeted Therapy Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Small-Molecules Features
Figure 5. Immunotoxins Features
Figure 6. Others Features
Figure 7. Global Injectable Targeted Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Injectable Targeted Therapy Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Homecare Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Injectable Targeted Therapy Report Years Considered
Figure 14. Global Injectable Targeted Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Injectable Targeted Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Injectable Targeted Therapy Market Share by Region: 2023 VS 2030
Figure 17. Global Injectable Targeted Therapy Market Share by Players in 2023
Figure 18. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Injectable Targeted Therapy Revenue in 2023
Figure 20. North America Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Injectable Targeted Therapy Market Share by Country (2019-2030)
Figure 22. United States Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Injectable Targeted Therapy Market Share by Country (2019-2030)
Figure 26. Germany Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Injectable Targeted Therapy Market Share by Region (2019-2030)
Figure 34. China Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Injectable Targeted Therapy Market Share by Country (2019-2030)
Figure 42. Mexico Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Injectable Targeted Therapy Market Share by Country (2019-2030)
Figure 46. Turkey Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 50. GSK Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 51. Bayer Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 52. Amgen Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 53. Merck Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 54. AbbiVie Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 55. AstraZeneca Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 56. Teva Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 57. Roche Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232